dalteparin has been researched along with Hematologic Malignancies in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Consecutive patients with hematologic malignancies requiring intensive chemotherapy including autologous stem cell transplantation were eligible." | 2.73 | Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. ( Baarslag, HJ; Biemond, BJ; Büller, HR; Di Nisio, M; Klerk, CP; Niers, TM, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niers, TM | 1 |
| Di Nisio, M | 1 |
| Klerk, CP | 1 |
| Baarslag, HJ | 1 |
| Büller, HR | 1 |
| Biemond, BJ | 1 |
| Campbell, PM | 1 |
| Ippoliti, C | 1 |
| Parmar, S | 1 |
| Herishanu, Y | 1 |
| Misgav, M | 1 |
| Kirgner, I | 1 |
| Ben-Tal, O | 1 |
| Eldor, A | 1 |
| Naparstek, E | 1 |
1 review available for dalteparin and Hematologic Malignancies
| Article | Year |
|---|---|
Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens.
Topics: Adult; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Centra | 2004 |
1 trial available for dalteparin and Hematologic Malignancies
| Article | Year |
|---|---|
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Catheters, Indwelling; Female; Hematologic Neoplasms; H | 2007 |
1 other study available for dalteparin and Hematologic Malignancies
| Article | Year |
|---|---|
Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
Topics: Aged; Anticoagulants; Enoxaparin; Female; Hematologic Neoplasms; Hemorrhage; Heparin, Low-Molecular- | 2017 |